VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,298 | -43.1% | 3,310 | -13.2% | 0.00% | – |
| Q2 2023 | $25,128 | -52.7% | 3,813 | -51.3% | 0.00% | – |
| Q1 2023 | $53,119 | -21.7% | 7,823 | -14.8% | 0.00% | – |
| Q4 2022 | $67,832 | +7.7% | 9,179 | +46.3% | 0.00% | – |
| Q3 2022 | $63,000 | -33.7% | 6,275 | -27.6% | 0.00% | – |
| Q2 2022 | $95,000 | +61.0% | 8,668 | +64.9% | 0.00% | – |
| Q1 2022 | $59,000 | -33.7% | 5,255 | -7.0% | 0.00% | – |
| Q4 2021 | $89,000 | +102.3% | 5,652 | +116.6% | 0.00% | – |
| Q3 2021 | $44,000 | -35.3% | 2,610 | -17.5% | 0.00% | – |
| Q2 2021 | $68,000 | +58.1% | 3,165 | +12.6% | 0.00% | – |
| Q1 2021 | $43,000 | +34.4% | 2,811 | +14.8% | 0.00% | – |
| Q4 2020 | $32,000 | +88.2% | 2,449 | +34.9% | 0.00% | – |
| Q3 2020 | $17,000 | -37.0% | 1,815 | -22.0% | 0.00% | – |
| Q2 2020 | $27,000 | +58.8% | 2,327 | +31.5% | 0.00% | – |
| Q1 2020 | $17,000 | -66.0% | 1,769 | -42.4% | 0.00% | – |
| Q4 2019 | $50,000 | +108.3% | 3,073 | +74.9% | 0.00% | – |
| Q3 2019 | $24,000 | -98.7% | 1,757 | -98.7% | 0.00% | -100.0% |
| Q2 2019 | $1,873,000 | -39.5% | 132,903 | -21.1% | 0.00% | -33.3% |
| Q1 2019 | $3,098,000 | -65.8% | 168,415 | -51.5% | 0.00% | -70.0% |
| Q4 2018 | $9,065,000 | +41.3% | 346,895 | +24.1% | 0.01% | +66.7% |
| Q3 2018 | $6,414,000 | +50.6% | 279,485 | +25.0% | 0.01% | +50.0% |
| Q2 2018 | $4,260,000 | +11.8% | 223,574 | -1.1% | 0.00% | 0.0% |
| Q1 2018 | $3,812,000 | -37.4% | 226,168 | -43.5% | 0.00% | -33.3% |
| Q4 2017 | $6,089,000 | -2.3% | 400,546 | +15.0% | 0.01% | 0.0% |
| Q3 2017 | $6,235,000 | +20.0% | 348,350 | +9.3% | 0.01% | 0.0% |
| Q2 2017 | $5,196,000 | +18.3% | 318,788 | +1.6% | 0.01% | +20.0% |
| Q1 2017 | $4,393,000 | -2.4% | 313,802 | +11.2% | 0.01% | 0.0% |
| Q4 2016 | $4,502,000 | +3.1% | 282,292 | +7.5% | 0.01% | 0.0% |
| Q3 2016 | $4,368,000 | +39609.1% | 262,498 | +26149.8% | 0.01% | – |
| Q2 2016 | $11,000 | +37.5% | 1,000 | 0.0% | 0.00% | – |
| Q1 2016 | $8,000 | -11.1% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $9,000 | -25.0% | 1,000 | -5.0% | 0.00% | – |
| Q3 2015 | $12,000 | – | 1,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |